An interventional study of High Frequency Chest Wall Oscillation and conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life. in Non Cystic Fibrosis Bronchiectasis, sponsored by Sphinx university. Not yet recruiting at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-28.
Sponsored by Sphinx university · Not applicable, Interventional, and Treatment
the study will concentrate on the effect of High Frequency Chest Wall Oscillation compared to conventional pulmonary physiotherapy on children with non cystic fibrosis bronchiectasis
The purpose of this study is to evaluate the effect of using HFCWO intervention on pulmonary functions in children with bronchiectasis.
it hypothesized that Using HFCWO has no effect on pulmonary functions and hospital stay in children with bronchiectasis.
Children subjected to the inclusion criteria will be assigned randomly into two groups, control group and study group.
Does high frequency chest wall oscillation (HFCWO) have an effect in pulmonary functions in children with bronchiectasis? RCT study Control group Patients in this group will be 30 children who will be treated by conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.
Study group This group will include 30 children who will use HFCWO for 20 minutes, in addition to 10 minutes of the same conventional program of physiotherapy given to the control group.
The frequency of treatment will be 5 sessions/week for three successive months for both groups for long term effect and daily for immediate effect.
outcome measure: FEV1, FVC, FEV1/FVC quality of life for bronchiectasis, 6-minute walk test
1,619 studies on the registry are indexed under Cystic Fibrosis; 199 are open to participants now.
This study's planned enrollment of 60 is above the median of 36 across 1,051 interventional studies indexed under Cystic Fibrosis.
Browse Cystic Fibrosis studies →This is the only study on the registry with Sphinx university as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children with no cystic fibrosis bronchiectasis
Exclusion Criteria:
Osteoporosis (Calcium deficiency)
This group will include 30 children who will use HFCWO for 20 minutes, in addition to 10 minutes of the same conventional program of physiotherapy given to the control group. The frequency of treatment will be 5 sessions/week for three successive months for both groups for long term effect and daily for immediate effect.
Device: High Frequency Chest Wall Oscillation
Patients in this group will be 30 children who will be treated by conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.
Other: conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.
High-frequency chest wall oscillation that applies external chest wall oscillations via an inflatable vest worn around the thoracic cage, increasing the air-liquid shear forces during expiration is believed to result in secretion mobilization. The product name that will be used is Air Way Clearness system; his model is PV-900/ PV-300/PV-100, made in China.
conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life. Conventional physiotherapy that will be applied to the control group for 30 minutes will include: * Postural drainage according to accumulation of secretions for 10 minutes accompanied by percussion or vibration * Active cycle breathing technique (ACBT) for 10 minutes * Respiratory exercises for 10 minutes
Forced Expiratory Volume in 1 second (FEV1)
Change in FEV1 measured by spirometry according to ATS/ERS guidelines
Time frame: Baseline and after 8 weeks of treatment
Forced Vital Capacity (FVC)
Change in FVC measured by spirometry according to ATS/ERS guidelines
Time frame: Baseline and after 6 months of treatment
FEV1/FVC Ratio
Change in FEV1/FVC ratio measured by spirometry according to ATS/ERS guidelines
Time frame: Baseline and after 6 months of treatment
Six-Minute Walk Distance (6MWD)
hange in functional exercise capacity assessed by the Six-Minute Walk Test (6MWT). The total distance walked in six minutes is recorded according to the American Thoracic Society (ATS) guidelines.
Time frame: Baseline and after 6 months of treatment
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.